Literature DB >> 18274931

An insight on hyaluronic acid in drug targeting and drug delivery.

Awesh K Yadav1, P Mishra, Govind P Agrawal.   

Abstract

Hyaluronic acid (HA) has recently been studied for its use in drug delivery applications. Medically, HA is used as a surgical aid in ophthalmology. It also possesses therapeutic potential in the treatment of arthritis and wound healing. HA-binding receptors, CD44 and receptor for hyaluronan-mediated motility have attracted much enthusiasm, mainly because they are believed to be involved in cancer metastasis. This review unravels the role of HA in drug delivery and targeting. Designing of various novel drug delivery systems using HA as a biopolymer will also be reviewed in the present article.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18274931     DOI： 10.1080/10611860802095494

Source DB:  PubMed          Journal:  J Drug Target        ISSN： 1026-7158            Impact factor:   5.121


  30 in total

1.  Influence of polymeric carrier on the disposition and retention of 20(R)-ginsenoside-rg3-loaded swellable microparticles in the lung.

Authors:  Xiuhua Wang; Xiao Zhang; Linlin Fan; Huan He; Xiaofei Zhang; Yuyang Zhang; Shirui Mao
Journal:  Drug Deliv Transl Res       Date:  2018-02       Impact factor: 4.617

Review 2.  Hyaluronan-CD44 interactions as potential targets for cancer therapy.

Authors:  Suniti Misra; Paraskevi Heldin; Vincent C Hascall; Nikos K Karamanos; Spyros S Skandalis; Roger R Markwald; Shibnath Ghatak
Journal:  FEBS J       Date:  2011-03-25       Impact factor: 5.542

Review 3.  Applications and emerging trends of hyaluronic acid in tissue engineering, as a dermal filler and in osteoarthritis treatment.

Authors:  A Fakhari; C Berkland
Journal:  Acta Biomater       Date:  2013-03-15       Impact factor: 8.947

4.  Hyaluronic acid based self-assembling nanosystems for CD44 target mediated siRNA delivery to solid tumors.

Authors:  Shanthi Ganesh; Arun K Iyer; David V Morrissey; Mansoor M Amiji
Journal:  Biomaterials       Date:  2013-02-11       Impact factor: 12.479

Review 5.  Role of hyaluronan and hyaluronan-binding proteins in lung pathobiology.

Authors:  Frances E Lennon; Patrick A Singleton
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-05-13       Impact factor: 5.464

6.  Instillation of hyaluronan reverses acid instillation injury to the mammalian blood gas barrier.

Authors:  Ting Zhou; Zhihong Yu; Ming-Yuan Jian; Israr Ahmad; Carol Trempus; Brant M Wagener; Jean-Francois Pittet; Saurabh Aggarwal; Stavros Garantziotis; Weifeng Song; Sadis Matalon
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-01-25       Impact factor: 5.464

7.  Intratumoral delivery of Paclitaxel in solid tumor from biodegradable hyaluronan nanoparticle formulations.

Authors:  Abeer M Al-Ghananeem; Ahmad H Malkawi; Yahya M Muammer; Justin M Balko; Esther P Black; Walid Mourad; Edward Romond
Journal:  AAPS PharmSciTech       Date:  2009-04-21       Impact factor: 3.246

Review 8.  Anticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor.

Authors:  Virginia M Platt; Francis C Szoka
Journal:  Mol Pharm       Date:  2008-06-03       Impact factor: 4.939

9.  Paclitaxel Nano-Delivery Systems: A Comprehensive Review.

Authors:  Ping Ma; Russell J Mumper
Journal:  J Nanomed Nanotechnol       Date:  2013-02-18

Review 10.  Graphene-based platforms for cancer therapeutics.

Authors:  Sunny C Patel; Stephen Lee; Gaurav Lalwani; Cassandra Suhrland; Sayan Mullick Chowdhury; Balaji Sitharaman
Journal:  Ther Deliv       Date:  2016-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.